The application of an antagonist targeting the critical ligand CXCR2 to block neutrophils recruitment reversed the progression of COPD aggravated by periodontitis, indicating the promotion of COPD by periodontal pathogens mainly through neutrophils. The gene discussed is CXCR2; the disease is chronic obstructive pulmonary disease.